United Guardian (UG) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
United Guardian (UG) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.28% |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 17.91% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 49.60% |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 16.87% |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | -31.77% |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -11.68% |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 39.37% |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 3.60% |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | 16.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.49% |
| Mar 31, 2026 | 2.76% |
| Dec 31, 2025 | -1.05% |
| Sep 30, 2025 | -9.07% |
| Jun 30, 2025 | -0.33% |
| Mar 31, 2025 | -14.95% |
| Dec 31, 2024 | -23.00% |
| Sep 30, 2024 | -5.12% |
| Jun 30, 2024 | -10.81% |
| Mar 31, 2024 | -7.89% |
| Dec 31, 2023 | 7.10% |
| Sep 30, 2023 | -4.57% |
| Jun 30, 2023 | -27.12% |
| Mar 31, 2023 | -1.56% |
| Dec 31, 2022 | -21.95% |
| Sep 30, 2022 | -31.56% |
| Jun 30, 2022 | -16.12% |
| Mar 31, 2022 | -9.41% |
| Dec 31, 2021 | 26.40% |
| Sep 30, 2021 | -8.33% |